{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T15:06:23Z","timestamp":1772291183285,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020MC184"],"award-info":[{"award-number":["ZR2020MC184"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["No. ZR2020MC074"],"award-info":[{"award-number":["No. ZR2020MC074"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00705-025-06274-w","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T02:58:47Z","timestamp":1743303527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Isolation, identification, and genome analysis of the novel Escherichia coli phage XH12 and enhancement of the antibacterial activity of its lysozyme by chimeric cationic peptides"],"prefix":"10.1007","volume":"170","author":[{"given":"Xuhao","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhai","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1815-0237","authenticated-orcid":false,"given":"Hongkuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"6274_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrmicro818","volume":"2","author":"JB Kaper","year":"2004","unstructured":"Kaper JB, Nataro JP, Mobley HLT (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2:123\u2013140","journal-title":"Nat Rev Microbiol"},{"key":"6274_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s42003-023-05745-7","volume":"7","author":"J Huang","year":"2024","unstructured":"Huang J, Lv C, Li M, Rahman T, Chang Y-F, Guo X, Song Z, Zhao Y, Li Q, Ni P (2024) Carbapenem-resistant Escherichia coli exhibit diverse spatiotemporal epidemiological characteristics across the globe. Commun Biology 7:51","journal-title":"Commun Biology"},{"key":"6274_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrmicro.2016.94","volume":"14","author":"H-C Flemming","year":"2016","unstructured":"Flemming H-C, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S (2016) Biofilms: an emergent form of bacterial life. Nat Rev Microbiol 14:563\u2013575","journal-title":"Nat Rev Microbiol"},{"key":"6274_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-med-042711-140023","volume":"64","author":"M Otto","year":"2013","unstructured":"Otto M (2013) Staphylococcal Infections: Mechanisms of Biofilm Maturation and Detachment as Critical Determinants of Pathogenicity. Annu Rev Med 64:175\u2013188","journal-title":"Annu Rev Med"},{"key":"6274_CR5","doi-asserted-by":"crossref","unstructured":"Wang X, Li Q, Kang J, Yin D, Li X, Wang S, Guo Q, Song Y, Wang J, Duan JJI, Resistance D (2022) Mortality risk factors and prognostic analysis of patients with multi-drug resistant enterobacterales infection. Infect Drug Resist 15:3225\u20133237","DOI":"10.2147\/IDR.S366808"},{"key":"6274_CR6","doi-asserted-by":"crossref","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli YJTL (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18(3):318\u2013327","DOI":"10.1016\/S1473-3099(17)30753-3"},{"key":"6274_CR7","doi-asserted-by":"crossref","unstructured":"Strathdee SA, Hatfull GF, Mutalik VK, Schooley RTJC (2023) Phage therapy: from biological mechanisms to future directions. Cell 186:17\u201331","DOI":"10.1016\/j.cell.2022.11.017"},{"key":"6274_CR8","doi-asserted-by":"crossref","unstructured":"Al-Shayeb B, Sachdeva R, Chen L-X, Ward F, Munk P, Devoto A, Castelle CJ, Olm MR, Bouma-Gregson K, Amano YJN (2020) Clades of huge phages from across Earth\u2019s ecosystems. Nature 578:425\u2013431","DOI":"10.1038\/s41586-020-2007-4"},{"key":"6274_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrmicro3564","volume":"13","author":"GPC Salmond","year":"2015","unstructured":"Salmond GPC, Fineran PC (2015) A century of the phage: past, present and future. Nat Rev Microbiol 13:777\u2013786","journal-title":"Nat Rev Microbiol"},{"key":"6274_CR10","first-page":"278","volume":"13","author":"M Breitbart","year":"2005","unstructured":"Breitbart M, Rohwer FJT (2005) Here a virus, there a virus. everywhere same virus? Trends Microbiol 13:278\u2013284","journal-title":"everywhere same virus?"},{"key":"6274_CR11","doi-asserted-by":"crossref","unstructured":"Pallavali RR, Degati VL, Narala VR, Velpula KK, Yenugu S, Durbaka VRPJT, Applications R (2021) Lytic bacteriophages against bacterial biofilms formed by multidrug-resistant Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus isolated from burn wounds. Ther, Appl Res 2:120\u2013130","DOI":"10.1089\/phage.2021.0004"},{"key":"6274_CR12","doi-asserted-by":"publisher","first-page":"119833","DOI":"10.1016\/j.ijpharm.2020.119833","volume":"589","author":"WCB Lai","year":"2020","unstructured":"Lai WCB, Chen X, Ho MKY, Xia J, Leung SSY (2020) Bacteriophage-derived endolysins to target gram-negative bacteria. Int J Pharm 589:119833","journal-title":"Int J Pharm"},{"key":"6274_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12275-014-4087-z","volume":"52","author":"R Young","year":"2014","unstructured":"Young R (2014) Phage lysis: three steps, three choices, one outcome. J Microbiol 52:243\u2013258","journal-title":"J Microbiol"},{"key":"6274_CR14","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3390\/antibiotics10121534","volume":"10","author":"P Ferraboschi","year":"2021","unstructured":"Ferraboschi P, Ciceri S, Grisenti P (2021) Applications of lysozyme, an innate immune defense factor, as an alternative antibiotic. Antibiotics 10:1534","journal-title":"Antibiotics"},{"key":"6274_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1515\/nbec-2015-0021","volume":"14","author":"V Jar\u00e1bkov\u00e1","year":"2015","unstructured":"Jar\u00e1bkov\u00e1 V, Ti\u0161\u00e1kov\u00e1 L, God\u00e1ny A (2015) Phage endolysin: a way to understand a binding function of C-terminal domains a mini review. Nova Biotechnol Chim 14:117\u2013134","journal-title":"Nova Biotechnol Chim"},{"key":"6274_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ijmm.2010.04.002","volume":"300","author":"VA Fischetti","year":"2010","unstructured":"Fischetti VA (2010) Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. Int J Med Microbiol 300:357\u2013362","journal-title":"Int J Med Microbiol"},{"key":"6274_CR17","doi-asserted-by":"crossref","unstructured":"Raz A, Serrano A, Lawson C, Thaker M, Alston T, Bournazos S, Ravetch JV, Fischetti VA (2017) Lysibodies are IgG Fc fusions with lysin binding domains targeting Staphylococcus aureus wall carbohydrates for effective phagocytosis. Proceedings of the National Academy of Sciences 114:4781\u20134786","DOI":"10.1073\/pnas.1619249114"},{"key":"6274_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/antibiotics9020074","volume":"9","author":"C Ghose","year":"2020","unstructured":"Ghose C, Euler CW (2020) Gram-negative bacterial lysins. Antibiotics 9:74","journal-title":"Antibiotics"},{"key":"6274_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0014-5793(01)02587-X","volume":"500","author":"M Morita","year":"2001","unstructured":"Morita M, Tanji Y, Orito Y, Mizoguchi K, Soejima A, Unno H (2001) Functional analysis of antibacterial activity of Bacillus amyloliquefaciens phage endolysin against Gram-negative bacteria. FEBS Lett 500:56\u201359","journal-title":"FEBS Lett"},{"key":"6274_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.01379-14","volume":"5","author":"Y Briers","year":"2014","unstructured":"Briers Y, Walmagh M, Van Puyenbroeck V, Cornelissen A, Cenens W, Aertsen A, Oliveira H, Azeredo J, Verween G, Pirnay J-P (2014) Engineered endolysin-based Artilysins to combat multidrug-resistant gram-negative pathogens. MBio 5:10\u20131128","journal-title":"MBio"},{"key":"6274_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10482-016-0806-2","volume":"110","author":"Q Ma","year":"2017","unstructured":"Ma Q, Guo Z, Gao C, Zhu R, Wang S, Yu L, Qin W, Xia X, Gu J, Yan G (2017) Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminus. Antonie Van Leeuwenhoek 110:347\u2013355","journal-title":"Antonie Van Leeuwenhoek"},{"key":"6274_CR22","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00705-019-04213-0","volume":"164","author":"Z Yang","year":"2019","unstructured":"Yang Z, Liu X, Shi Y, Yin S, Shen W, Chen J, Chen Y, Chen Y, You B, Gong Y, Luo X, Zhang C, Yuan Z, Peng Y (2019) Characterization and genome annotation of a newly detected bacteriophage infecting multidrug-resistant Acinetobacter baumannii. Arch Virol 164:1527\u20131533","journal-title":"Arch Virol"},{"key":"6274_CR23","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s00705-022-05472-0","volume":"167","author":"Y Yin","year":"2022","unstructured":"Yin Y, Wang X, Mou Z, Ren H, Zhang C, Zou L, Liu H, Liu W, Liu Z (2022) Characterization and genome analysis of Pseudomonas aeruginosa phage vB_PaeP_Lx18 and the antibacterial activity of its lysozyme. Arch Virol 167:1805\u20131817","journal-title":"Arch Virol"},{"key":"6274_CR24","doi-asserted-by":"crossref","unstructured":"Ding Y, Zhang Y, Huang C, Wang J, Wang X (2020) An endolysin lysSE24 by bacteriophage LPSE1 confers specific bactericidal activity against multidrug-resistant salmonella strains. Microorganisms 8(5):737","DOI":"10.3390\/microorganisms8050737"},{"key":"6274_CR25","doi-asserted-by":"crossref","unstructured":"Kim S, Jin J-S, Choi Y-J, Kim J (2020) LysSAP26, a new recombinant phage endolysin with a broad spectrum antibacterial activity. Viruses 12(11):1340","DOI":"10.3390\/v12111340"},{"key":"6274_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/antibiotics10010069","volume":"10","author":"N Puva\u010da","year":"2021","unstructured":"Puva\u010da N, de Llanos Frutos R (2021) Antimicrobial resistance in Escherichia coli strains isolated from humans and pet animals. Antibiotics 10:69","journal-title":"Antibiotics"},{"key":"6274_CR27","doi-asserted-by":"crossref","unstructured":"Peng Z, Wang X, Huang J, Li B (2024) Pathogenic Escherichia coli. Molecular Medical Microbiology. Elsevier 1065\u20131096","DOI":"10.1016\/B978-0-12-818619-0.00069-1"},{"key":"6274_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/1120009X.2017.1380395","volume":"29","author":"A Mazzariol","year":"2017","unstructured":"Mazzariol A, Bazaj A, Cornaglia G (2017) Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review. J Chemother 29:2\u20139","journal-title":"J Chemother"},{"key":"6274_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1057\/s41599-020-0478-4","volume":"6","author":"C Brives","year":"2020","unstructured":"Brives C, Pourraz J (2020) Phage therapy as a potential solution in the fight against AMR: obstacles and possible futures. Palgrave Commun 6:1\u201311","journal-title":"Palgrave Commun"},{"key":"6274_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/CMR.00066-18","volume":"32","author":"FL Gordillo Altamirano","year":"2019","unstructured":"Gordillo Altamirano FL, Barr JJ (2019) Phage therapy in the postantibiotic era. Clin Microbiol Rev 32:10\u20131128","journal-title":"Clin Microbiol Rev"},{"key":"6274_CR31","doi-asserted-by":"crossref","unstructured":"Rahmani R, Zarrini G, Sheikhzadeh F, Aghamohammadzadeh N (2015) Effective phages as green antimicrobial agents against antibiotic-resistant hospital Escherichia coli. Jundishapur J Microbiol 8(2):e17744","DOI":"10.5812\/jjm.17744"},{"key":"6274_CR32","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/antibiotics9080466","volume":"9","author":"T De Miguel","year":"2020","unstructured":"De Miguel T, Rama JLR, Sieiro C, S\u00e1nchez S, Villa TG (2020) Bacteriophages and lysins as possible alternatives to treat antibiotic-resistant urinary tract infections. Antibiotics 9:466","journal-title":"Antibiotics"},{"key":"6274_CR33","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3390\/ph16101467","volume":"16","author":"KM Chung","year":"2023","unstructured":"Chung KM, Liau XL, Tang SS (2023) Bacteriophages and Their Host Range in Multidrug-Resistant Bacterial Disease Treatment. Pharmaceuticals 16:1467","journal-title":"Pharmaceuticals"},{"key":"6274_CR34","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3389\/fmicb.2016.01352","volume":"7","author":"A Ross","year":"2016","unstructured":"Ross A, Ward S, Hyman P (2016) More is better: selecting for broad host range bacteriophages. Front Microbiol 7:1352","journal-title":"Front Microbiol"},{"key":"6274_CR35","doi-asserted-by":"publisher","first-page":"8572","DOI":"10.1038\/s41467-024-52595-w","volume":"15","author":"F Kunisch","year":"2024","unstructured":"Kunisch F, Campobasso C, Wagemans J, Yildirim S, Chan BK, Schaudinn C, Lavigne R, Turner PE, Raschke MJ, Trampuz A (2024) Targeting Pseudomonas aeruginosa biofilm with an evolutionary trained bacteriophage cocktail exploiting phage resistance trade-offs. Nat Commun 15:8572","journal-title":"Nat Commun"},{"key":"6274_CR36","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.cell.2020.05.005","volume":"181","author":"JK Martin","year":"2020","unstructured":"Martin JK, Sheehan JP, Bratton BP, Moore GM, Mateus A, Li SH-J, Kim H, Rabinowitz JD, Typas A, Savitski MM (2020) A dual-mechanism antibiotic kills gram-negative bacteria and avoids drug resistance. Cell 181:1518\u20131532","journal-title":"Cell"},{"key":"6274_CR37","doi-asserted-by":"crossref","unstructured":"Taati Moghadam M, Amirmozafari N, Shariati A, Hallajzadeh M, Mirkalantari S, Khoshbayan A, Masjedian Jazi F (2020) How phages overcome the challenges of drug resistant bacteria in clinical infections. Infect Drug Resist 45\u201361","DOI":"10.2147\/IDR.S234353"},{"key":"6274_CR38","doi-asserted-by":"publisher","first-page":"198496","DOI":"10.1016\/j.virusres.2021.198496","volume":"302","author":"S Malik","year":"2021","unstructured":"Malik S, Nehra K, Rana JS (2021) Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli. Virus Res 302:198496","journal-title":"Virus Res"},{"key":"6274_CR39","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3390\/molecules27061857","volume":"27","author":"J Lin","year":"2022","unstructured":"Lin J, Du F, Long M, Li P (2022) Limitations of phage therapy and corresponding optimization strategies: a review. Molecules 27:1857","journal-title":"Molecules"},{"key":"6274_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","volume":"186","author":"SA Strathdee","year":"2023","unstructured":"Strathdee SA, Hatfull GF, Mutalik VK, Schooley RT (2023) Phage therapy: From biological mechanisms to future directions. Cell 186:17\u201331","journal-title":"Cell"},{"key":"6274_CR41","doi-asserted-by":"publisher","first-page":"e108376","DOI":"10.1371\/journal.pone.0108376","volume":"9","author":"H Oliveira","year":"2014","unstructured":"Oliveira H, Thiagarajan V, Walmagh M, Sillankorva S, Lavigne R, Neves-Petersen MT, Kluskens LD, Azeredo J (2014) A thermostable Salmonella phage endolysin, Lys68, with broad bactericidal properties against gram-negative pathogens in presence of weak acids. PLoS ONE 9:e108376","journal-title":"PLoS ONE"},{"key":"6274_CR42","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2217\/fmb.12.97","volume":"7","author":"M Schmelcher","year":"2012","unstructured":"Schmelcher M, Donovan DM, Loessner MJ (2012) Bacteriophage endolysins as novel antimicrobials. Future Microbiol 7:1147\u20131171","journal-title":"Future Microbiol"},{"key":"6274_CR43","doi-asserted-by":"publisher","first-page":"8523","DOI":"10.3390\/ijms24108523","volume":"24","author":"C Varotsou","year":"2023","unstructured":"Varotsou C, Premetis GE, Labrou NE (2023) Characterization and engineering studies of a new endolysin from the Propionibacterium acnes bacteriophage PAC1 for the development of a broad-spectrum artilysin with altered specificity. Int J Mol Sci 24:8523","journal-title":"Int J Mol Sci"},{"key":"6274_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13568-019-0838-x","volume":"9","author":"G Yan","year":"2019","unstructured":"Yan G, Yang R, Fan K, Dong H, Gao C, Wang S, Yu L, Cheng Z, Lei L (2019) External lysis of Escherichia coli by a bacteriophage endolysin modified with hydrophobic amino acids. Amb Express 9:1\u20137","journal-title":"Amb Express"},{"key":"6274_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1128\/MMBR.00037-15","volume":"80","author":"H Dang","year":"2016","unstructured":"Dang H, Lovell CR (2016) Microbial Surface Colonization and Biofilm Development in Marine Environments. Microbiol Mol Biol Rev 80:91\u2013138","journal-title":"Microbiol Mol Biol Rev"},{"key":"6274_CR46","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/pharmaceutics14020427","volume":"14","author":"S Liu","year":"2022","unstructured":"Liu S, Lu H, Zhang S, Shi Y, Chen Q (2022) Phages against pathogenic bacterial biofilms and biofilm-based infections: a review. Pharmaceutics 14:427","journal-title":"Pharmaceutics"},{"key":"6274_CR47","first-page":"1478","volume":"6","author":"S Niveditha","year":"2012","unstructured":"Niveditha S, Pramodhini S, Umadevi S, Kumar S, Stephen S (2012) The isolation and the biofilm formation of uropathogens in the patients with catheter associated urinary tract infections (UTIs). J Clin Diagn research: JCDR 6:1478","journal-title":"J Clin Diagn research: JCDR"},{"key":"6274_CR48","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.jksus.2019.11.037","volume":"32","author":"MA Almalki","year":"2020","unstructured":"Almalki MA, Varghese R (2020) Prevalence of catheter associated biofilm producing bacteria and their antibiotic sensitivity pattern. J King Saud University-Science 32:1427\u20131433","journal-title":"J King Saud University-Science"},{"key":"6274_CR49","doi-asserted-by":"publisher","first-page":"e799","DOI":"10.1371\/journal.pone.0000799","volume":"2","author":"AM Comeau","year":"2007","unstructured":"Comeau AM, T\u00e9tart F, Trojet SN, Pr\u00e8re M-F, Krisch HM (2007) Phage-antibiotic synergy (PAS): \u03b2-lactam and quinolone antibiotics stimulate virulent phage growth. PLoS ONE 2:e799","journal-title":"PLoS ONE"},{"key":"6274_CR50","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.3390\/v6103778","volume":"6","author":"LB Coulter","year":"2014","unstructured":"Coulter LB, McLean RJC, Rohde RE, Aron GM (2014) Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilms. Viruses 6:3778\u20133786","journal-title":"Viruses"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-025-06274-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-025-06274-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-025-06274-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T05:20:47Z","timestamp":1746508847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-025-06274-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["6274"],"URL":"https:\/\/doi.org\/10.1007\/s00705-025-06274-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5333939\/v1","asserted-by":"object"}]},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"91"}}